Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: A multicenter, cross-sectional study

AIDS and Behavior

Volumn 8, Issue 2, 2004, Pages 141-150

  Reynolds, Nancy R ^a   Testa, Marcia A ^b   Marc, Linda G ^b   Chesney, Margaret A ^c   Neidig, Judith L ^a   Smith, Scott R ^d   Vella, Stefano ^e   Robbins, Gregory K ^f  

^a OHIO STATE UNIVERSITY   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; CELL COUNT; COGNITION; CORRELATION ANALYSIS; DEMOGRAPHY; DISTRESS SYNDROME; DRUG EFFICACY; EDUCATION; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MALE; PERCEPTION; QUESTIONNAIRE; REGRESSION ANALYSIS; ROLE PLAYING; SCORING SYSTEM; SCREENING; SELF CONCEPT; SOCIAL SUPPORT; STRESS; SYMPTOM; WELLBEING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGE FACTORS; ANTI-RETROVIRAL AGENTS; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; SELF EFFICACY; SOCIAL SUPPORT; STRESS, PSYCHOLOGICAL;

EID: 3042829202     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:AIBE.0000030245.52406.bb     Document Type: Article

References (36)

1. Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., Bamberger, J. D., Chesney, M. A., and Moss, A. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14, 357-366.
2. Bangsberg, D. R., Hecht, F. M., Clague, H., Charlebois, E. D., Ciccarone, D., Chesney, M., and Moss, A. (2002). Provider assessment of adherence to HIV antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 26, 435-442.
3. Becker, M. H. (1974). The health belief model and personal health behavior. Health Education Monographs, 2, 324-508.
4. Becker, M. H. (1988). AIDS and behavior change. Public Health Reviews, 16, 1-11.
5. Catz, S. L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., and McAliffe, T. L. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19, 124-133.
6. Chesney, M. A., Morin, M., and Sherr, L. (2000a). Adherence to HIV combination therapy. Social Science and Medicine, 50, 1599-1605.
7. Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., and Wu, A. W. (2000b). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instrument. AIDS Care, 12, 255-266.
8. Gao, X., Nau, D. P., Rosenbluth, S. A., Scott, V., and Woodward, C. (2000). The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care, 12, 387-398.
9. Gordillo, V., del Amo, J., Soriano, V., and Gonzalez-Lahoz, J. (1999). Socioeconomic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13, 1763-1769.
10. Haddad, M., Inch, C., Glazier, R. H., Wilkins, A. L., Urbshott, G., Bayoumi, A., and Rourke, S. (2002). Patient support and education for promoting adherence to highly active anitiretroviral therapy for HIV/AIDS. The Cochrane Library, 4, Oxford: Update Software.
11. Ickovics, J. R., and Meade, C. S. (2002). Adherence to HAART among patients with HIV: Breakthroughs and barriers, AIDS Care, 14, 309-318.
12. Janz, N. K., and Becker, M. H. (1984). The health belief model: A decade later. Health Education Quarterly, 11, 1-47.
13. Justice, A. C., Holmes, W., Gifford, A. L., Rabeneck, L., Zackin, R., Sinclair, G., Weissman, S., Neidig, J., Marcus, C., Chesney, M., Cohn, S. E., and Wu, A. (2001). Development and validation of a self-completed HIV symptom index. Journal of Clinical Epidemiology, 54, S77-S90.
14. Karon, J. M., Fleming, P. L., Steketee, R. W., and De Cock, K. M. (2001). HIV in the United States at the turn of the century. American Journal of Public Health, 91, 1060-1068.
15. Kind, P., Dolan, P., Gudewx, C., and Williams, A. (1998). Variations in population health status: Results from a United Kingdom national questionnaire survey. British Medical Journal, 316, 737-741.
16. Lucas, G. M., Gebo, K. A., Chaisson, R. E., and Moore, R. D. (2002). Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS, 16, 767-774.
17. Mannheimer, S., Friedland, G., Matts, J., Child, C., and Chesney, M. (2002). The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clinical Infectious Diseases, 34, 1115-1121.
18. Montgomery, S. B., Joseph, J. G., Becker, M. H., Ostrow, D. G., Kessler, R. C., and Kirscht, J. P. (1989). The health belief model in understanding compliance with preventive recommendation for AIDS: How useful? AIDS Education and Prevention, 1, 303-323.
19. Murphy, D. A., Wilson, C. M., Durako, S. J., Muenz, L. R., and Belzer, M. (2001a). Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care, 13, 27-40.
20. Murphy, E. L., Collier, A. C., Kalish, L. A., Assmann, S. F., Para, M. F., Flanigan, T. P., Kumar, P. N., Mintz, L., Wallach, F. R., and Nemo, G. J. (2001b). Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Annals of Internal Medicine, 135, 17-26.
21. Nieuwkerk, P. Y., Sprangers, M. A., Burger, D. M., Hoetelmans, R. M., Hugen, P. W., Danner, S. A., vab Der Ende, M. E., Schneider, M. M., Schrey, G., Meenhorst, P. L., Sprenger, H. G., Kauffmann, R. H., Jambroes, M., Chesney, M. A., de Wolf, F., and Lange, J. M. (2001). Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort. Archives of Internal Medicine, 161, 1962-1968.
22. Ostrop, N. J., Hallet, K. A., and Gill, M. J. (2000). Long-term patient adherence to antiretroviral therapy. Annals of Pharmacotherapy, 34, 703-709.
23. Palella F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuher, J., Satten, G. A., Aschman, D. J., and Holmberg, S. D. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine, 338, 853-860.
24. Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., Wagener, M. M., and Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-30.
25. Radloff, L. S. (1977) The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385-401.
26. Reynolds, N. R., Testa, M. A., Su, M., Chesney, M. A., and Robbins, G. K. for the Protocol Teams of ACTG 384. (July, 2003). Baseline predictors of adherence and regimen failure in treatment naïve HIV+ subjects (ACTG 384). Presented at the 2nd IAS Conference on HIV Pathogenesis and Treatment, Paris.
27. Safren, S. A., Worth, J. L., Salomon, E., Johnson, W., Mayer, K., and Boswell, S. (2001). Two strategies to increase adherence to HIV antiretroviral medication: Life steps and medication monitoring. Behavioral Research and Therapy, 39, 11151-1162.
28. Schroeder, J. R., Latkin, C. A., Hoover, D. R., Knowlton, A. R., Zenilman, J., Strathdee, S., and Celantano, D. D. (2001). Social factors related to antiretroviral therapy use in injection drug users. AIDS and Behavior, 5, 363-369.
29. Schuman, P., Ohmit, S. E., Cohen, M., Sacks, H. S., Richardson, J., Young, M., Schoenbaum, E., Rompalo, A., and Gardner, L. (2001). Prescription of and adherence to antiretroviral therapy among women with AIDS. AIDS and Behavior, 5, 371-378.
30. Smeaton, L. M., DeGruttola, V., Robbins, G. K., and Shafer, R. W. (2001). ACTG (AIDS Clinical Trials Group 384): A strategy trial comparing consecutive treatments for HIV-1. Controlled Clinical Trials, 22, 142-159.
31. Spire, B., Duran, S., Souville, M., Leport, C., Raffi, F., and Moatti, J. P. (2002). Adherence to highly active antiretroviral therapy: From a predictive to a dynamic approach. Social Science and Medicine, 54, 1481-1496.
32. SPSS Inc. (2002). SPSS version 11.5. Chicago: Author.
33. Volberding, P. (2002). Adherence, resistance and timing: Current issues in the use of new therapies. AIDS Reader, 12, 349-357, 368.
34. Wu, A. W., Rubin, H. R., Matthews, W. C., Ware, J. E., Brysk, L. T., Hardy, W. D., Bozzette, S. A., Spector, S. A., and Richman, D. D. (1991). A health status questionnaire using items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection. Medical Care, 29, 786-798.
35. Wu, A. W., Jacobson, D. L., Frick, K. D., Clark, R., Revicki, D. A., Freedberg, K. A., Scott-Lennox, J., and Feinberg, J. (2002). Validity and responsiveness of the EuroQol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial. Quality of Life Research, 11, 273-282.
36. Yeni, P. G., Hammer, S. M., Carpenter, C., Cooper, D. A., Fischl, M. A., Gatell, J. M., Gazzard, B. G., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S., Richman, D. D., Saag, M. S., Schechter, M., Schooley, R. T., Thompson, M. A., Vella, S., and Volberding, P. A. (2002). Antiretroviral treatment for adult HIV infection in 2002: Updated recommendations of the International AIDS Society - USA Panel. JAMA, 288, 222-235.